Downregulation of TRAP1 leads to the degradation of proliferation markers, such as Ki67, CDK1, and MAD2, in breast, colorectal, and lung cancer models, sensitizing these cells to agents that target the cell cycle machinery. The gene discussed is TRAP1; the disease is lung carcinoma.